Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Tax Provisions: 2019-2025

Historic Tax Provisions for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $459,576.

  • CureVac N.V's Tax Provisions rose 132.80% to $459,576 in Q2 2025 from the same period last year, while for Jun 2025 it was $31.8 million, marking a year-over-year increase of 1789.74%. This contributed to the annual value of $30.7 million for FY2024, which is 14293.50% up from last year.
  • Latest data reveals that CureVac N.V reported Tax Provisions of $459,576 as of Q2 2025, which was up 201.84% from -$451,258 recorded in Q1 2025.
  • CureVac N.V's Tax Provisions' 5-year high stood at $67.5 million during Q4 2024, with a 5-year trough of -$35.7 million in Q3 2024.
  • In the last 3 years, CureVac N.V's Tax Provisions had a median value of -$17,422 in 2023 and averaged $3.0 million.
  • Examining YoY changes over the last 5 years, CureVac N.V's Tax Provisions showed a top increase of 27,068.68% in 2024 and a maximum decrease of 546,845.59% in 2024.
  • CureVac N.V's Tax Provisions (Quarterly) stood at $1.2 million in 2021, then crashed by 124.09% to -$291,791 in 2022, then soared by 185.18% to $248,542 in 2023, then skyrocketed by 27,068.68% to $67.5 million in 2024, then surged by 132.80% to $459,576 in 2025.
  • Its Tax Provisions stands at $459,576 for Q2 2025, versus -$451,258 for Q1 2025 and $67.5 million for Q4 2024.